AUMOLERTINIB

UNII:	T4RS462G19
Type:	INGREDIENT SUBSTANCE
Formula:	C₃₀H₃₅N₇O₂
Preferred Substance Name:	AUMOLERTINIB
InChIKey:	DOEOECWDNSEFDN-UHFFFAOYSA-N
GSRS Full Record:	T4RS462G19 i

1899921-05-1
2-Propenamide, N-[5-[[4-(1-cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-
AUMOLERTINIB [USAN]
Aumolertinib
Aumolertinib [WHO-DD]
EGFR T790M INHIBITOR HS-10296
EQ-143
EQ143
HS-10296
N-[5-[[4-(1-Cyclopropyl-1H-indol-3-yl)-2-pyrimidinyl]amino]-2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxyphenyl]-2-propenamide
N-[5-[[4-(1-cyclopropylindol-3-yl)pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide
almonertinib
aumolertinib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

AUMOLERTINIB

Synonyms and Mappings

Resources